EUVIMEDEUVIMED entdecken
Crossref

Targeting G3BP1-Mediated Stress Granules to Suppress SARS-CoV-2 Replication

Rukayat Aromokeye, Lisha Kuang, Martha Ackerman-Berrier, Savio Cardoza, Cameron Holberg, Megan Carver, Chunlong Ma, Anil Mathew Tharappel, Hongmin Li, Lei Wang, Gregory R J Thatcher, Haining Zhu iD

ACS Infectious Diseases · 09.10.2026 · 12 (10) · 3322-3334

DOI: 10.1021/acsinfecdis.5c01026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 10.04.2026. Verfasst von Rukayat Aromokeye und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, Arizona85721, United States. Hauptthemen laut MEDLINE: RNA Recognition Motif Proteins, Poly-ADP-Ribose Binding Proteins, RNA Helicases, Stress Granules. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: BLRD VA, NINDS NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stress granules (SGs) are cytoplasmic, membraneless assemblies of proteins and RNAs that transiently form in response to cellular stress. Dysregulation of SGs has been associated with cancer, neurodegeneration, and viral infection. GTPase-activating protein SH3 domain-binding protein 1 (G3BP1) is a central SG component that regulates granule assembly and dynamics through protein-RNA and protein–protein interactions (PPIs). During viral infection, SGs can be hijacked to enhance viral replication and suppress host defense. In this study, we show that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid protein (N) binds G3BP1 and localizes to G3BP1-positive SGs in infected cells. We hypothesize that small-molecule ligands targeting G3BP1 can disrupt the G3BP1-N interaction and reduce viral replication. To test this, we developed a robust, miniaturized, 384-well time-resolved fluorescence resonance energy transfer (TR-FRET) assay for high-throughput screening (HTS). Screening a library of 2560 FDA-approved drugs yielded 17 hits. Subsequent counterscreening, validation, and biophysical binding studies identified 7 PPI inhibitors with IC50 values ranging from 0.8 to 31 μM. In cell-based assays, two compounds─dexlansoprazole and citalopram─disrupted the G3BP1-N interaction with minimal cytotoxicity. Both compounds showed antiviral activity in human lung epithelial cells infected with either the WA strain or an Omicron (BA.1) strain of SARS-CoV-2. This work establishes a strategy to modulate SGs by targeting a host–virus PPI, highlighting G3BP1 as a potential therapeutic node for antiviral intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA Recognition Motif ProteinsPoly-ADP-Ribose Binding ProteinsRNA HelicasesStress GranulesDNA HelicasesSARS-CoV-2Virus ReplicationAntiviral AgentsCOVID-19 Drug TreatmentHumansCoronavirus Nucleocapsid ProteinsProtein BindingFluorescence Resonance Energy TransferPhosphoproteinsAnimalsCOVID-19

Stichwörter der Autor:innen

G3BP1SARS-CoV-2nucleocapsid proteinprotein–protein interaction inhibitorstress granules

Substanzen

RNA Recognition Motif ProteinsPoly-ADP-Ribose Binding ProteinsG3BP1 protein, humanRNA HelicasesDNA HelicasesCoronavirus Nucleocapsid ProteinsAntiviral Agentsnucleocapsid phosphoprotein, SARS-CoV-2Phosphoproteins

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, Arizona85721, United States.
  • Department of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona85721, United States.
  • The BIO5 Institute, University of Arizona, Tucson, Arizona85721, United States.
  • Department of Molecular & Cellular Biology, College of Science, University of Arizona, Tucson, Arizona85721, United States.
  • Research Service, Department of Veteran Affairs Southern Arizona Health Care, Tucson, Arizona85713, United States.

ORCID-Profile: Haining Zhu

Förderung

  • BLRD VA
  • NINDS NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • U.S. Department of Veterans Affairs
  • University of Arizona
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Aromokeye, R., Kuang, L., Ackerman-Berrier, M., Cardoza, S., Holberg, C., Carver, M., Ma, C., Tharappel, A. M., Li, H., Wang, L., Thatcher, G. R. J., & Zhu, H. (2026). Targeting G3BP1-Mediated Stress Granules to Suppress SARS-CoV-2 Replication. ACS Infectious Diseases, 12(10), 3322-3334. https://doi.org/10.1021/acsinfecdis.5c01026

Vancouver

Aromokeye R, Kuang L, Ackerman-Berrier M, Cardoza S, Holberg C, Carver M, et al. Targeting G3BP1-Mediated Stress Granules to Suppress SARS-CoV-2 Replication. ACS Infectious Diseases. 2026;12(10):3322-3334. doi:10.1021/acsinfecdis.5c01026

BibTeX
@article{Aromokeye2026,
  author = {Aromokeye, Rukayat and Kuang, Lisha and Ackerman-Berrier, Martha and Cardoza, Savio and Holberg, Cameron and Carver, Megan and Ma, Chunlong and Tharappel, Anil Mathew and Li, Hongmin and Wang, Lei and Thatcher, Gregory R J and Zhu, Haining},
  title = {Targeting G3BP1-Mediated Stress Granules to Suppress SARS-CoV-2 Replication},
  journal = {ACS Infectious Diseases},
  year = {2026},
  volume = {12},
  number = {10},
  pages = {3322--3334},
  doi = {10.1021/acsinfecdis.5c01026}
}
Kostenlos starten →